These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 39175578)
1. Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis. Qin C; Cai S; Qi Y; Liu M; Xu W; Yin M; Tang H; Ji Q; Liao T; Wang Y Front Endocrinol (Lausanne); 2024; 15():1453601. PubMed ID: 39175578 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for recurrent disease in small papillary thyroid cancers - a Swedish register-based study. Bayadsi H; Nylén C; Sandström M; Angelsten J; Sund M; Hennings J Langenbecks Arch Surg; 2023 Apr; 408(1):162. PubMed ID: 37099203 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Wu MH; Shen WT; Gosnell J; Duh QY Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456 [TBL] [Abstract][Full Text] [Related]
5. Effect of skip metastasis to lateral neck lymph nodes on outcome of patients with papillary thyroid carcinoma. Bertin JB; Buffet C; Leenhardt L; Menegaux F; Chereau N Langenbecks Arch Surg; 2022 Nov; 407(7):3025-3030. PubMed ID: 35819485 [TBL] [Abstract][Full Text] [Related]
6. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis. Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863 [TBL] [Abstract][Full Text] [Related]
7. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome. Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475 [TBL] [Abstract][Full Text] [Related]
8. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study. Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319 [TBL] [Abstract][Full Text] [Related]
9. Impact of thyroid carcinoma invasion of recurrent laryngeal nerve on cervical lymph node metastasis. Zhu F; Shen Y; Zhu L; Chen L; Li F; Xie X; Wu Y Endocrine; 2024 Nov; 86(2):654-663. PubMed ID: 38767775 [TBL] [Abstract][Full Text] [Related]
10. The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study. Yang Z; Heng Y; Zhao Q; Hao D; Tao L; Deng X; Cai W; Qiu W Cancer Med; 2023 Jun; 12(12):13270-13278. PubMed ID: 37140212 [TBL] [Abstract][Full Text] [Related]
11. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management. Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis. Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303 [TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma. Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026 [TBL] [Abstract][Full Text] [Related]
15. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma. Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552 [TBL] [Abstract][Full Text] [Related]
16. Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid Carcinoma. Wu Y; Li J; Wu X; Dai L Curr Pharm Des; 2018; 24(5):559-563. PubMed ID: 28990528 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for lateral lymph node metastasis of papillary thyroid carcinoma in children. Ngo DQ; Le DT; Ngo QX; Van Le Q J Pediatr Surg; 2022 Oct; 57(10):421-424. PubMed ID: 35168812 [TBL] [Abstract][Full Text] [Related]
18. Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study. Shuai Y; Yue K; Duan Y; Zhou M; Fang Y; Liu J; Liu D; Jing C; Wu Y; Wang X Front Endocrinol (Lausanne); 2021; 12():620147. PubMed ID: 34211434 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients. Lu Y; Jiang L; Chen C; Chen H; Yao Q Medicine (Baltimore); 2020 Apr; 99(15):e19795. PubMed ID: 32282744 [TBL] [Abstract][Full Text] [Related]
20. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]